MRK

Merck Opens New Manufacturing Facility in Hangzhou, China

[at noodls] – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the opening of its new pharmaceutical manufacturing facility in Hangzhou, China. The facility, located in the Hangzhou … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to […]

Merck and Luminex Corporation Enter Agreement to Develop Companion Diagnostic to Support Investigational BACE inhibitor Clinical Development Program for Alzheimer’s Disease

[at noodls] – WHITEHOUSE STATION, N.J. & AUSTIN, Texas–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Luminex Corporation (NASDAQ:LMNX) have signed a collaboration and license … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]

Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization Agreement

[Business Wire] – WHITEHOUSE STATION, N.J. & SEOUL, South Korea–(BUSINESSWIRE)– Merck, (NYSE: MRK) known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., entered into an agreement to develop … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]

BioPharm Insight – Sirona in active discussions to out-license preclinical SGLT-2 antidiabetic candidate – CEO

[at noodls] – by Christine Livoti in New York December 14, 2012 Sirona Biochem (TSX-V:SBM) is in active talks for the licensing of its preclinical antidiabetic candidate, SBM-TFC-039, in Asia and North America, said … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to […]

Merck Increases Quarterly Dividend

[at noodls] – Dateline: This increase in our dividend reflects our optimism about the future of our business and our commitment to providing value to our shareholders, WHITEHOUSE STATION, N.J.–(BUSINESS … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Endocyte – A Safe Bet for 2013

[ACN Newswire] – By David Sobek Endocyte (NASDAQ:ECYT) recently confirmed that the Marketing Authorization Application (MAA) filing process for vintafolide and etarfolatide in Europe is set to be completed by the end of … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboard […]

Merck Announces Third-Quarter 2012 Financial Results

[at noodls] – 2012 Third-Quarter Non-GAAP EPS Increased to $0.95, Excluding Certain Items; GAAP EPS of $0.56 Worldwide Sales of $11.5 Billion, a Decrease of 4 Percent; Comparable to Third-Quarter 2011 Sales, Excluding … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: MRK Earnings Upside; Top-Line Miss No Big Deal, Dividend Continues To Support

[ACN Newswire] – By David MoskowitzMerck & Co. (NYSE:MRK) reported better than expected earnings Friday morning, with EPS of $0.95 vs. the Street Consensus of $0.93. While 3Q total revenues came in below expectations ($11.49 … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboard […]

Merck to Move Global Headquarters Within New Jersey

[at noodls] – Company cites ongoing facilities consolidation and reiterates commitment to reduce operating expenses Dateline: The relocation of our headquarters will help us achieve our future vision, reduce the … moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboard […]